Antibiotics in Necrotizing Soft Tissue Infections.

Area of Science:

• Infectious Diseases
• Bacteriology
• Pharmacology

Background:

• Necrotizing soft tissue infections (NSTIs) are severe, rapidly progressing bacterial infections.
• NSTIs involve extensive necrosis of skin and subcutaneous tissues, posing a life-threatening risk.
• Urgent management includes antibiotics, surgical debridement, and intensive care for organ failure.

Purpose of the Study:

• To review current knowledge on antibiotic use in Necrotizing soft tissue infections (NSTIs).
• To highlight challenges in antibiotic therapy for NSTIs.
• To discuss optimal antibiotic selection, adjuncts, and duration for NSTI management.

Main Methods:

• Literature review of current knowledge on antibiotic therapy for NSTIs.
• Analysis of antibiotic requirements including spectrum, toxin inhibition, and tissue penetration.
• Discussion of empirical antibiotic choices and adjunctive therapies.

Main Results:

• Antibiotic therapy for NSTIs must cover polymicrobial infections and potential multidrug resistance.
• Broad-spectrum beta-lactam antibiotics (e.g., piperacillin-tazobactam) are standard empirical treatment.
• Clindamycin is recommended to reduce toxin production, especially for Group A Streptococcus.

Conclusions:

• Effective antibiotic management of NSTIs requires broad-spectrum coverage, consideration of toxin production, and optimized tissue diffusion.
• Pharmacokinetic/pharmacodynamic alterations in NSTI patients necessitate careful antibiotic selection.
• The optimal duration of antibiotic treatment for NSTIs remains between 7 and 15 days.